Abstract:Background: We previously reported that endogenous prostaglandin I(2), generated by a mild irritant, sensitised calcitonin gene related peptide (CGRP) containing sensory nerves and facilitated the release of CGRP and gastric mucosal protection against ethanol. Administration of capsaicin also inhibited ethanol induced gastric mucosal injury through immediate release of CGRP from primary sensory neurones, which is termed the neural emergency system. In the present study, we tested whether endogenous prostaglandin I(2) also modulates the cytoprotective action of capsaicin using prostaglandin I receptor knockout mice (IP(-/-)). Methods: The stomachs of IP(-/-) or their wild-type counterparts (IP(+/+)), anaesthetised with urethane (1.225 g/kg), were doubly cannulated from the oesophageal and duodenal sides, and the gastric mucosa was perfused (1 ml/min) with physiological saline. Perfusate was changed to 50% ethanol alone, or 50% ethanol containing capsaicin (16 approximately 1600 micro M). The injured area was estimated at the end of each perfusion experiment. In some animals, CGRP-(8-37), a CGRP antagonist (0.3 mg/kg), or indomethacin (1 mg/kg) was intravenously injected before perfusion of 50% ethanol containing capsaicin. Results: Capsaicin inhibited the injured area in a dose dependent manner. Fifty per cent ethanol containing capsaicin (480 micro M) immediately increased intragastric levels of CGRP although 50% ethanol alone did not. The protective action of capsaicin (480 micro M) against ethanol was completely abolished by intravenous injection of CGRP-(8-37). Indomethacin also inhibited the protective action of capsaicin, and this was accompanied by reduced levels of intragastric CGRP. Intragastric levels of prostaglandin E(2) were not increased by capsaicin treatment but those of 6-keto-prostaglandin F(1alpha), a metabolite of prostaglandin I(2), were markedly increased. No protective action of capsaicin was observed in IP(-/-) which lacked the ability to increase intragastric CGRP levels in response to ethanol containing capsaicin. The CGRP content of the stomach from untreated IP(-/-) did not differ from those in IP(+/+). Capsaicin (160 micro M) together with intragastric perfusion of beraprost sodium (PGI(2) analogue, 2.5 micro g/ml) showed enhanced protection against ethanol induced injury. This enhanced protection was completely blocked by intravenous injection of CGRP-(8-37). Conclusions: The present results suggest that endogenous prostaglandin I(2) enhances the protective action of the capsaicin mediated neural emergency system against ethanol induced gastric mucosal injury through enhancement of CGRP release.

Involvement of calcitonin gene-related peptide and capsaicin-sensitive afferents in central thyrotropin-releasing hormone-induced hepatic cytoprotection

The Approach to the Mechanism of Calcitonin Gene-Related Peptide-Inducing Inhibition of Food Intake.

Stimulation of Calcitonin Gene-Related Peptide Release Through Targeting Capsaicin Receptor: A Potential Strategy for Gastric Mucosal Protection

Calcitonin gene-related peptide protects rats from cerebral ischemia/reperfusion injury via a mechanism of action in the MAPK pathway

Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone.

TRPV1 controls acid- and heat-induced calcitonin gene-related peptide release and sensitization by bradykinin in the isolated mouse trachea

Allyl isothiocyanate, an activator of TRPA1, increases gastric mucosal blood flow through calcitonin gene-related peptide and adrenomedullin in anesthetized rats

Involvement of calcitonin gene-related peptide and its receptor in anti-nociception in the periaqueductal grey of rats.

Up-regulation of Calcitonin Gene-Related Peptide Protects Streptozotocin-Induced Diabetic Hearts from Ischemia/reperfusion Injury

Calcitonin gene-related peptide in the rat kidney: Occurrence, sensitivity to capsaicin, and stimulation of adenylate cyclase

Ccl2 and Cxcl1 Trigger Calcitonin Gene-Related Peptide Release by Exciting Primary Nociceptive Neurons

Calcitonin Gene-Related Peptide in the Pathogenesis and Treatment of Hypertension.

Calcitonin Gene-Related Peptide Modulates Heat Nociception in the Human Brain - An fMRI Study in Healthy Volunteers

Calcitonin gene‐related peptide‐mediated pharmacological effects in cardiovascular and gastrointestinal diseases (Review)

Calcitonin Gene-Related Peptide and Its Receptor Plays Important Role in Nociceptive Regulation in the Arcuate Nucleus of Hypothalamus of Rats with Inflammatory Pain.

Calcitonin Gene-Related Peptide is One of the Mediators for the Interactions of Neural-Immune Systems

Bipartite Activation of Sensory Neurons by a TRPA1 Agonist Allyl Isothiocyanate Is Reflected by Complex Ca2+ Influx and CGRP Release Patterns: Enhancement by NGF and Inhibition with VAMP and SNAP-25 Cleaving Botulinum Neurotoxins

Effects of Calcitonin Gene-Related Peptide-(8-37) on Withdrawal Responses in Rats with Inflammation

[Modulatory Action of Alpha 2-Adrenoceptor on Calcitonin Gene-Related Peptide Release from Rat Mesenteric Arterial Bed].

Endogenous prostaglandin I2 regulates the neural emergency system through release of calcitonin gene related peptide

Calcitonin Gene-Related Peptide Protects Against Hypertension-Induced Heart and Kidney Damage